E-LIB Suche - Ergebnisse für: Kreuzer, Karl

1

The use of circulating cell-free tumor DNA in routine diagn..:

Knuever, Jana ; Weiss, Jonathan ; Persa, Oana-Diana...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7080785/. , 2020

Link: http://www.ncbi.nlm.nih...

2

Culpa in contrahendo und Verkehrspflichten. Ein rechtsvergl..:

Kreuzer, Karl
https://opus.bibliothek.uni-wuerzburg.de/frontdoor/index/index/docId/11645. , 1971

Link: https://opus.bibliothek...

3

Author Correction: Transcriptomic profiles and 5-year resul..:

Al-Sawaf, Othman ; Zhang, Can ; Jin, Hyun Yong...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10593794/. , 2023

Link: http://www.ncbi.nlm.nih...

4

General condition and comorbidity of long-term survivors of..:

Goekbuget, Nicola ; Ihrig, Kristina ; Stadler, Michael...
https://freidok.uni-freiburg.de/data/236286. , 2023

Link: https://freidok.uni-frei..

5

Tislelizumab plus zanubrutinib for Richter transformation: ..:

Al-Sawaf, Othman ; Ligtvoet, Rudy ; Robrecht, Sandra...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10803258/. , 2023

Link: http://www.ncbi.nlm.nih...

6

Transcriptomic profiles and 5-year results from the randomi..:

Al-Sawaf, Othman ; Zhang, Can ; Jin, Hyun Yong...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10113251/. , 2023

Link: http://www.ncbi.nlm.nih...

7

S200: IBRUTINIB VERSUS PLACEBO IN PATIENTS WITH ASYMPTOMATI..:

Langerbeins, Petra ; Robrecht, Sandra ; Nieper, Pascal...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428394/. , 2023

Link: http://www.ncbi.nlm.nih...

8

General condition and comorbidity of long-term survivors of..:

Gökbuget, Nicola ; Ihrig, Kristina ; Stadler, Michael...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10316257/. , 2023

Link: http://www.ncbi.nlm.nih...

9

S145: VENETOCLAX-OBINUTUZUMAB FOR PREVIOUSLY UNTREATED CHRO..:

Al-Sawaf, Othman ; Robrecht, Sandra ; Zhang, Can...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428511/. , 2023

Link: http://www.ncbi.nlm.nih...

10

P630: SAFETY AND TREATMENT ADHERENCE WITH ACALABRUTINIB IN ..:

Simon, Florian ; Ligtvoet, Rudy ; Noesslinger, Thomas...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429528/. , 2023

Link: http://www.ncbi.nlm.nih...

11

P622: GENETIC MARKERS AND OUTCOME OF CLL PATIENTS IN COMBIN..:

Yosifov, Deyan ; von Tresckow, Julia ; Giza, Adam...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429433/. , 2023

Link: http://www.ncbi.nlm.nih...

12

P586: POTENTIAL DRUG-DRUG INTERACTIONS OF ANTIFUNGAL PROPHY..:

Joisten, Carolin ; Müller, Carsten ; Mellinghoff, Sibylle...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429035/. , 2023

Link: http://www.ncbi.nlm.nih...

13

Sequential treatment with bendamustine, obinutuzumab (GA101..:

von Tresckow, Julia ; Cramer, Paula ; Robrecht, Sandra...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9343250/. , 2022

Link: http://www.ncbi.nlm.nih...

14

Evaluation of a Prognostic Epigenetic Classification System..:

Grimm, Christina ; Herling, Carmen Diana ; Komnidi, Anastasia...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8793417/. , 2022

Link: http://www.ncbi.nlm.nih...

15

Minimal Residual Disease Dynamics after Venetoclax-Obinutuz..:

Al-Sawaf, Othman ; Zhang, Can ; Lu, Tong...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8678026/. , 2021

Link: http://www.ncbi.nlm.nih...